{"title": "FDA Approves Longer Use of Valcyte\u00ae for Adult Kidney Transplant Patients at High Risk of Developing Cytomegalovirus", "author": null, "url": "https://www.fiercepharma.com/pharma/fda-approves-longer-use-of-valcyte%C2%AE-for-adult-kidney-transplant-patients-at-high-risk-of", "hostname": "fiercepharma.com", "description": "-- CMV is the Most Important and Common Viral Infection Complicating Solid Organ Transplantation -- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: | -- CMV is the Most Important and Common Viral Infection Complicating Solid Organ Transplantation -- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX:", "sitename": "FiercePharma", "date": "2010-08-10", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}